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Background
The prevalence of overweight and obesity worldwide has
resulted in the growth of over the counter weight loss
products into one the largest categories of nutritional
supplements. However, few commercial products have
been properly examined in finished commercial form
and seldom have been studied in comparison with indi-
vidual active ingredients. The purpose of this study was
to investigate the acute effects of the commercial weight
loss/energy product, Fastin-XR® (High-Tech Pharma-
ceuticals, Inc., Norcross, GA) on measures of metabolic
and hemodynamic activity in comparison with the
effects of caffeine and the effects of acacia rigidula.
Methods
Ten recreationally active men, 28.5 ± 5 years of age,
voluntarily participated in this investigation. Study partici-
pants completed four 3-hour resting metabolic testing
sessions in which four treatment conditions including
Fastin-XRR (FAS), 300 mg caffeine anhydrous (CAF), 250
mg acacia rigidula extract (AC), and cellulose placebo
condition (PL) were examined in randomized order. Phy-
siological activity was determined in 15 minute intervals
immediately prior to and 1hr, 2hrs, and 3 hrs following
ingestion. Metabolic activity was determined with open
flow spirometry (VO2000, Medgraphics, St. Paul, MN)
with outcomes including oxygen consumption (VO2),
respiratory exchange ratio (RER), minute ventilation (VE)
and oxygen extraction (VO2/VE). Hemodynamic activity
was examined by measurement of heart rate (HR) and
blood pressures (SBP, DBP). Values of metabolic and
hemodynamic variables were adjusted into change scores
relative to baseline levels. Statistical analyses were con-
ducted using a 4x3 ANOVA for repeated measures with
the accepted level of significance set at p<0.05.
Results
The VO2 change scores for 1hr, 2hrs, and hrs post inges-
tion were significantly greater with FAS (22.1%, 19.3%,
16.5%) compared with P (-2.6%, -1.7%, -2.0%), C (9.9%,
8.5%, 3.5%) and with AC (12.0%, 9.3%, 12.5%). The AC
condition produced significantly greater VO2 compared
with PL at all three time points with CAF displaying
values greater than PL at 1hr and 2hrs post ingestion. No
significant main or interaction effects were detected in
values of RER. The FAS condition produced significantly
greater elevations in VE compared with PL at all three
time points. Both CAF and AC produced significantly
greater VE change scores than PL, at 1hr post ingestion.
Values of VO2/VE were significantly reduced from base-
line at 1hr and 2hrs post with FAS and were significantly
lower at 1hr post with CAF while AC produced eleva-
tions in VO2/VE of 5%, 4%, 7%. The changes in HR were
significantly greater with FAS than PL at 2hrs and 3hrs
post (9.4 and 11.1bpm) while AC resulted in 2.5 and 4.1
bpm greater HR at 1hr and 2hrs post which were signifi-
cantly greater than P. FAS produced significantly greater
blood pressure changes at all three time points compared
with PL (SBP↑33%, 26%, 19%; DBP↑26%, 10%, 15%).
Changes in DBP were significantly greater than PL with
CAF at 1hr (9.4%) and 2hrs (7.1%). Blood pressures were
not significantly affected by AC.
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Conclusions
These findings indicate that resting energy expenditure
is significantly enhanced with Fastin-XRR, 300 mg caf-
feine anhydrous, or 250 mg acacia rigidula. Hemody-
namic activity (HR, SBP, DBP) is significantly elevated
with Fastin-XRR with modest effects displayed with caf-
feine or acacia.
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